Day Malcolm Raymond reported grant involving 1,350,000 derivative units of Critical Metals Corp. on Nov 12, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 16, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
—Shares × reported price
Shares traded
1,350,000Option (Right to Buy)
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 12, 2026Grant
Filed
Nov 16, 2026, 9:40 PM ET5-day reporting delay
Accession
0001213900-26-121032Code A · Transaction 402413
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 12, 2026Disposition to issuer1,350,000——Trade 402412
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

CRML price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CRML · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 24, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago +33%1d ago +34%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on November 12, 2026 (the "Effective Date"). The Option Repricing applies to options with exercise prices equal to $12.88 per share (the "Original Exercise Price") held by the reporting person as of the Effective Date. Each stock option at the Original Exercise Price was amended such that the exercise price is now $5.31. F2: Represents a right to receive an option for one ordinary share of the Issuer, par value $0.001 per share ("Ordinary Shares"). The Ordinary Shares underlying the options vest, if at all, based on the achievement of a certain volume weighted average price per Ordinary Share for any trailing twenty (20) consecutive trading days ("VWAP") beginning on or after November 28, 2025, as determined, approved and certified by the Compensation Committee of the Board of Directors. Pursuant to the Option Repricing, the options will vest upon satisfaction of the following thresholds: 1/3rd upon the achievement of a $6.65 VWAP through October 31, 2026, 1/3rd upon the achievement of a $8.30 VWAP through October 31, 2027, and 1/3rd upon the achievement of a $10.37 VWAP through October 31, 2028. Any tranche of options that has not vested by the last day of the applicable period shall automatically terminate.